13.51
price down icon0.59%   -0.08
after-market 시간 외 거래: 13.55 0.04 +0.30%
loading

Kalvista Pharmaceuticals Inc (KALV) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
28.16%
55.03
42.94 45.81 44.22 48.45
Operating Income/Loss
28.16%
-55.03
-42.94 -45.81 -44.22 -48.45
Nonoperating Income/Loss
247.43%
1.949
-1.322 3.543 3.772 3.806
Income/Loss From Continuing Operations Before Tax
19.92%
-53.08
-44.26 -42.27 -40.44 -44.65
Income Tax Expense/Benefit
120.13%
-0.855
4.247 - - -
Income/Loss From Continuing Operations After Tax
7.66%
-52.23
-48.51 -42.27 -40.44 -44.65
Net Income/Loss
7.66%
-52.23
-48.51 -42.27 -40.44 -44.65
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
97.85%
1.1305
52.64 46.70 46.23 2.2187
Diluted Average Shares
97.85%
1.1305
52.64 46.70 46.23 2.2187
Basic Earnings Per Share
7.61%
-0.99
-0.92 -0.91 -0.87 -1.07
Diluted Earnings Per Share
7.61%
-0.99
-0.92 -0.91 -0.87 -1.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$25.11
price up icon 1.33%
$83.70
price down icon 1.34%
$24.42
price down icon 1.55%
$101.93
price down icon 1.05%
$134.97
price up icon 0.33%
biotechnology ONC
$297.96
price down icon 0.73%
자본화:     |  볼륨(24시간):